Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link

2 weeks ago 5

ARTICLE AD BOX

Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.

Read Entire Article

Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link

ARTICLE AD BOX

Related

HSBC stock slumps after $14 billion bet on Hong Kong — at a ...

Inflation angst lingers for investors even as Treasury yield...

Higher costs, smaller dogs and more cat adoptions are all hi...

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Netflix scuttles plans to add six previously announced games...

Steam will label early access games that haven't been update...

OpenAI co-founder John Schulman has left Anthropic after les...

‘I didn’t want to spend time with my children. I was just go...